179 related articles for article (PubMed ID: 9511040)
1. Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages.
Sato K; Akaki T; Tomioka H
J Antimicrob Chemother; 1998 Jan; 41(1):77-83. PubMed ID: 9511040
[TBL] [Abstract][Full Text] [Related]
2. [In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
Akaki T; Sato K; Shimizu T; Tomioka H; Kawahara S
Kekkaku; 1997 Aug; 72(8):491-7. PubMed ID: 9293712
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
Sato K; Tomioka H; Akaki T; Kawahara S
Int J Antimicrob Agents; 2000 Sep; 16(1):25-9. PubMed ID: 11185410
[TBL] [Abstract][Full Text] [Related]
4. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
Sato K; Ogasawara K; Akaki T; Tomioka H
Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
[TBL] [Abstract][Full Text] [Related]
5. [Effects of half-sized secretory leukocyte protease inhibitor and Chinese traditional medicines, yokuinin and mao-bushi-saishin-to, on therapeutic efficacies of benzoxazinorifamycin KRM-1648 against Mycobacterium avium complex infection induced in mice].
Sato K; Shimizu T; Tomioka H; Kawahara S
Kekkaku; 1998 Aug; 73(8):501-6. PubMed ID: 9780605
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells.
Sato K; Tomioka H
J Antimicrob Chemother; 1999 Mar; 43(3):351-7. PubMed ID: 10223590
[TBL] [Abstract][Full Text] [Related]
7. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
Tomioka H; Saito H
Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
[TBL] [Abstract][Full Text] [Related]
8. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
Sato K; Tomioka H
Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
[TBL] [Abstract][Full Text] [Related]
9. Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.
Bermudez LE; Kolonoski P; Young LS; Inderlied CB
Antimicrob Agents Chemother; 1994 Aug; 38(8):1844-8. PubMed ID: 7986018
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice].
Shimizu T; Tomioka H; Sato K; Akaki T; Ogasawara K; Kawahara S
Kekkaku; 1999 Aug; 74(8):617-21. PubMed ID: 10487030
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
Shimizu T; Tomioka H; Sato K; Sano C; Akaki T; Dekio S; Yamada Y; Kamei T; Shibata H; Higashi N
Antimicrob Agents Chemother; 1999 Mar; 43(3):514-9. PubMed ID: 10049260
[TBL] [Abstract][Full Text] [Related]
12. Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages.
Inderlied CB; Barbara-Burnham L; Wu M; Young LS; Bermudez LE
Antimicrob Agents Chemother; 1994 Aug; 38(8):1838-43. PubMed ID: 7986017
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice.
Tomioka H; Saito H; Sato K; Yamane T; Yamashita K; Hosoe K; Fujii K; Hidaka T
Antimicrob Agents Chemother; 1992 Feb; 36(2):387-93. PubMed ID: 1605603
[TBL] [Abstract][Full Text] [Related]
14. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
[TBL] [Abstract][Full Text] [Related]
15. How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?
Ji B; Lounis N; Truffot-Pernot C; Grosset J
Antimicrob Agents Chemother; 1996 Feb; 40(2):437-42. PubMed ID: 8834894
[TBL] [Abstract][Full Text] [Related]
16. [Anti-Mycobacterium avium complex activities of KRM-1648, clarithromycin and levofloxacin in 7HSF medium at peak or average blood concentrations after their oral administration of clinical dosages].
Sato K; Akaki T; Tomioka H
Kekkaku; 1997 Jul; 72(7):449-53. PubMed ID: 9259129
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.
Hirata T; Saito H; Tomioka H; Sato K; Jidoi J; Hosoe K; Hidaka T
Antimicrob Agents Chemother; 1995 Oct; 39(10):2295-303. PubMed ID: 8619585
[TBL] [Abstract][Full Text] [Related]
18. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Tomioka H; Sato K; Kajitani H; Akaki T; Shishido S
Antimicrob Agents Chemother; 2000 Feb; 44(2):283-6. PubMed ID: 10639351
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
Saito H; Tomioka H; Sato K; Kawahara S; Hidaka T; Dekio S
Tuber Lung Dis; 1995 Feb; 76(1):51-8. PubMed ID: 7718848
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]